The US biotech sector has seen major upheaval and contraction over the first half of 2022, which is only just beginning to reverse. The pace and the numbers of employees affected over such a short period has been described as unprecedented by many observers.
All the latest mergers and acquisitions, major projects and investments throughout the industry.Read the latest business digest
Get your product noticed. Let C&I give it the profile it deserves. Contact Genevieve Kanowski on +49 6201606 638 or by email email@example.com to get into the next Supply Line.